UnitedHealth Group

UnitedHealth Group
Name	UnitedHealth Group
Type	Public
Traded as	NYSE: UNH, S&P 500 component, Dow Jones Industrial Average component
Industry	Managed health care
Founded	0 1977
Founder	Richard T. Burke
Hq location city	Minnetonka, Minnesota
Hq location country	United States
Key people	Andrew Witty (CEO), Stephen J. Hemsley (Executive Chairman)
Products	Health insurance, Pharmacy benefit management, Health care technology

Contents

History
Business segments
Financial performance
Corporate governance
Controversies and legal issues
See also

UnitedHealth Group. It is a diversified American managed health care and insurance company, serving as one of the largest in the world by revenue. Headquartered in Minnetonka, Minnesota, its operations span health insurance under the UnitedHealthcare brand, pharmacy benefit management via OptumRx, and extensive health care technology and services through its Optum division. The company is a component of both the Dow Jones Industrial Average and the S&P 500, reflecting its significant role in the United States economy and the global health care industry.

History

The company was founded in 1977 by Richard T. Burke as Charter Med Incorporated, initially focusing on health care cost management for physicians. It underwent a significant transformation under the leadership of William W. McGuire, who served as CEO from 1991 to 2006 and aggressively expanded its managed care operations. A pivotal moment came with the 2003 acquisition of Mid Atlantic Medical Services, which greatly bolstered its national health plan presence. The creation of the Optum business segment in 2011 marked a strategic shift towards health services and information technology, diversifying beyond traditional insurance. Subsequent major acquisitions have included the pharmacy benefit manager Catamaran Corporation in 2015 and the South American health benefits provider Amil Participações.

Business segments

Its operations are divided into two primary, distinct business platforms. The UnitedHealthcare segment provides a full spectrum of health care coverage, including employer-sponsored group health insurance, individual plans, Medicare Advantage and Medicaid plans, and military health care services through TRICARE contracts. The Optum segment is organized into three main divisions: OptumHealth offers direct care delivery and population health management services, OptumInsight provides data analytics and technology consulting to hospitals and physician groups, and OptumRx operates as one of the nation's largest pharmacy benefit managers, handling prescription drug claims and mail-order pharmacy services.

Financial performance

It consistently ranks at the top of the Fortune 500 list, often as the highest-graded entity within the health care industry based on total revenue. Its financial growth has been driven by both organic expansion in its core insurance membership and strategic acquisitions across its Optum services divisions. The company's revenue streams are diversified across premiums from UnitedHealthcare, service fees from OptumInsight, and pharmaceutical revenue from OptumRx. This performance has made it one of the most valuable components of the Dow Jones Industrial Average, with its market capitalization reflecting investor confidence in the stability of the health care sector.

Corporate governance

The company is led by a Board of Directors that includes several prominent figures from business and public policy, such as former U.S. Comptroller General David M. Walker. Andrew Witty, former head of the pharmaceutical giant GlaxoSmithKline, serves as the Chief Executive Officer. Previous long-time CEO Stephen J. Hemsley now holds the position of Executive Chairman. Key committees within the board oversee areas like audit compliance, executive compensation, and corporate governance norms, with policies shaped by regulations from the Securities and Exchange Commission and listing requirements of the New York Stock Exchange.

Controversies and legal issues

The company has faced numerous legal and regulatory challenges over its operational practices. It reached a landmark settlement with the New York State Attorney General and the American Medical Association in 2009 over allegations of systematically underpaying out-of-network medical claims. Its Medicare Advantage plans have been under repeated scrutiny from the U.S. Department of Justice and the U.S. Senate for potential risk adjustment coding practices that allegedly inflate government payments. Other significant issues have included a massive data breach at its Change Healthcare subsidiary in 2024, which disrupted claims processing nationwide, and ongoing antitrust investigations by the Federal Trade Commission related to its acquisition strategies and market dominance in certain regions.